JP2008524311A - 注射可能な獣医学組成物 - Google Patents
注射可能な獣医学組成物 Download PDFInfo
- Publication number
- JP2008524311A JP2008524311A JP2007547484A JP2007547484A JP2008524311A JP 2008524311 A JP2008524311 A JP 2008524311A JP 2007547484 A JP2007547484 A JP 2007547484A JP 2007547484 A JP2007547484 A JP 2007547484A JP 2008524311 A JP2008524311 A JP 2008524311A
- Authority
- JP
- Japan
- Prior art keywords
- florfenicol
- pyrrolidone
- composition according
- ether
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
R1−[O−(CH2)2]x−OR2(I)
(式中、R1はC1から5のアルキルまたはテトラヒドロフルフリルであり、
R2は水素、C1から5のアルキルまたはテトラヒドロフルフリルであり、および
xは、1から6の、特に1から4の、最も特に約2の整数である。)
のジ−または部分−エーテルである。
成分 重量/ml、
フロルフェニコール 45g、
N−メチル−2−ピロリドン(NMP) 30g、
ジエチレングリコールモノエチルエーテル 全容量が100mlになるまで、
から調製する。
成分 重量/ml
フロルフェニコール 45g、
N−メチル−2−ピロリドン(NMP) 30g、
グリコフロール 全容量が100mlになるまで、
から調製する。
成分 重量/ml
フロルフェニコール 40g、
N−メチル−2−ピロリドン(NMP) 30g、
ジエチレングリコールモノエチルエーテル 全容量が100mlになるまで
成分 重量/ml
フロルフェニコール 40g、
N−メチル−2−ピロリドン(NMP) 30g、
グリコフロール 全容量が100mlになるまで
成分 重量/ml
フロルフェニコール 45g、
N−メチル−2−ピロリドン(NMP) 37g、
グリコフロール 全容量が100mlになるまで
成分 重量/ml
フロルフェニコール 30g、
N−メチル−2−ピロリドン(NMP) 30g、
ジエチレングリコールモノエチルエーテル 全容量が100mlになるまで
成分 重量/ml
フロルフェニコール 45g、
N−メチル−2−ピロリドン(NMP) 35g、
ジエチレングリコールモノエチルエーテル 全容量が100mlになるまで
調合物AおよびBならびに参照の従来技術調合物を、40mg/kgのフロルフェニコールの投与量で206から279kgBWのウシに皮下投与した。
実験2において、調合物A、EおよびFの薬物動態学的パラメータを、参照の従来技術調合物と比較して評価した。
Claims (10)
- 溶媒系中にフロルフェニコールを含む、動物における微生物感染の治療のための組成物であり、前記溶媒系が、1,2−エタンジオールオリゴマーまたはポリマーのエーテルおよびピロリドン溶媒を含むことを特徴とする、前記組成物。
- 1,2−エタンジオールオリゴマーまたはポリマーのエーテルが、ジエチレングリコールモノエチルエーテルおよびテトラヒドロフルフリルアルコールポリエチレングリコールエーテルからなる群より選択されることを特徴とする、請求項1に記載の組成物。
- 1,2−エタンジオールオリゴマーまたはポリマーのエーテルが、ジエチレングリコールモノエチルエーテルであることを特徴とする、請求項2に記載の組成物。
- フロルフェニコールが、30%から45%w/vの量で存在することを特徴とする、請求項1から3に記載の組成物。
- ピロリドン溶媒が、2−ピロリドンおよびN−メチル−2−ピロリドンからなる群より選択されることを特徴とする、請求項1から4に記載の組成物。
- フロルフェニコールに対するピロリドン溶媒の量の比が、0.6から1.1の間であることを特徴とする、請求項1から5に記載の組成物。
- 1から89%v/vの1,2−エタンジオールオリゴマーまたはポリマーのエーテルおよび1から89%w/vのピロリドン溶媒を含むことを特徴とする、請求項1から6に記載の組成物。
- フロルフェニコール 45g、
N−メチル−2−ピロリドン(NMP) 35g、
ジエチレングリコールモノエチルエーテル 全容量が100mlになるまで、
からなる、請求項1から7に記載の医薬組成物。 - フロルフェニコール 45g、
N−メチル−2−ピロリドン(NMP) 30g、
ジエチレングリコールモノエチルエーテル 全容量が100mlになるまで、
からなる、請求項1から7に記載の医薬組成物。 - 動物における微生物感染の治療または予防のための医薬を製造するための、請求項1から9に記載の組成物の使用。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63815404P | 2004-12-21 | 2004-12-21 | |
US60/638,154 | 2004-12-21 | ||
EP04106809.9 | 2004-12-21 | ||
EP04106809 | 2004-12-21 | ||
PCT/EP2005/056950 WO2006067138A2 (en) | 2004-12-21 | 2005-12-20 | Injectable veterinary composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008524311A true JP2008524311A (ja) | 2008-07-10 |
JP5017122B2 JP5017122B2 (ja) | 2012-09-05 |
Family
ID=36498916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007547484A Active JP5017122B2 (ja) | 2004-12-21 | 2005-12-20 | 注射可能な獣医学組成物 |
Country Status (17)
Country | Link |
---|---|
US (1) | US8680154B2 (ja) |
EP (1) | EP1830885B1 (ja) |
JP (1) | JP5017122B2 (ja) |
AR (1) | AR052827A1 (ja) |
AT (1) | ATE411046T1 (ja) |
AU (1) | AU2005318187B2 (ja) |
BR (1) | BRPI0519157B8 (ja) |
CA (1) | CA2591307C (ja) |
DE (1) | DE602005010479D1 (ja) |
DK (1) | DK1830885T3 (ja) |
ES (1) | ES2315942T3 (ja) |
MX (1) | MX2007007528A (ja) |
NO (1) | NO338532B1 (ja) |
PL (1) | PL1830885T3 (ja) |
PT (1) | PT1830885E (ja) |
SI (1) | SI1830885T1 (ja) |
WO (1) | WO2006067138A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016515609A (ja) * | 2013-04-02 | 2016-05-30 | テミス メディケア リミティド | ジエチレングリコールモノエチルエーテル又は他のアルキル誘導体を含む医薬活性成分の組成物 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR044437A1 (es) | 2003-05-29 | 2005-09-14 | Schering Plough Ltd | Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino |
CA2672795A1 (en) * | 2006-12-13 | 2008-06-26 | Schering-Plough Ltd. | Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof |
FR2925335B1 (fr) * | 2007-12-21 | 2010-03-19 | Ceva Sante Animale | Compositions orales liquides de florfenicol diluables dans l'eau de boisson |
KR20110038723A (ko) * | 2008-07-30 | 2011-04-14 | 인터벳 인터내셔널 비.브이. | 플로르페니콜에 대한 중간체로서 유용한 옥사졸린-보호된 아미노디올 화합물의 제조 방법 |
BRPI1002021A2 (pt) | 2010-01-21 | 2012-05-22 | Nanocore Biotecnologia S A | composições farmacêuticas para tratamento de infecções bacterianas |
BRPI1002023A2 (pt) | 2010-03-01 | 2011-10-25 | Nanocore Biotecnologia S A | forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas |
CN102973498A (zh) * | 2012-12-13 | 2013-03-20 | 江苏恒丰强生物技术有限公司 | 一种氟苯尼考注射液及其制备方法 |
CN108653213A (zh) * | 2018-06-05 | 2018-10-16 | 王琴 | 一种氟苯尼考粉及其制备方法 |
CN108969486A (zh) * | 2018-06-05 | 2018-12-11 | 王琴 | 一种氟苯尼考可溶性粉及其制备方法 |
CN108743541A (zh) * | 2018-06-24 | 2018-11-06 | 王琴 | 水溶性兽药制剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003097054A1 (en) * | 2002-05-20 | 2003-11-27 | Schering-Plough Ltd. | Compositions and method for treating infection in cattle and swine |
WO2004014340A1 (en) * | 2002-08-13 | 2004-02-19 | Dae Han New Pharm Co., Ltd. | Injectable composition comprising florfenicol as an active ingredient |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL52533A (en) * | 1977-07-15 | 1980-01-31 | Abic Ltd | Injectable chloramphenicol composition |
US4235892A (en) * | 1979-02-05 | 1980-11-25 | Schering Corporation, Patent Dept. | 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor |
ES8104203A1 (es) * | 1979-02-05 | 1981-04-16 | Schering Corp | Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol |
US5105009A (en) * | 1983-06-02 | 1992-04-14 | Zambon S.P.A. | Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives |
IT1173213B (it) * | 1984-02-03 | 1987-06-18 | Zambon Spa | Procedimento per fluorurare alcuni derivati dall'1l-fenil-2-ammino-1,3-propandiolo e loro intermedi |
US5332835A (en) * | 1984-02-03 | 1994-07-26 | Zambon S.P.A. | Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process |
US4973750A (en) * | 1984-09-19 | 1990-11-27 | Schering Corporation | Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols |
US4582918A (en) * | 1984-09-19 | 1986-04-15 | Schering Corporation | Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols |
IT1197481B (it) * | 1986-09-15 | 1988-11-30 | Zambon Spa | Preparazione farmaceutica per uso veterinario |
US4876352A (en) * | 1988-09-14 | 1989-10-24 | Schering Corporation | Pressurized fluorination of hydroxy alkyl groups |
US5227494A (en) * | 1988-09-14 | 1993-07-13 | Schering Corporation | Process for preparing oxazoline compounds |
US5082863A (en) | 1990-08-29 | 1992-01-21 | Schering Corporation | Pharmaceutical composition of florfenicol |
HU212617B (en) * | 1990-10-25 | 1996-09-30 | Schering Corp | Process for preparating florfenicol and its analogs thereto |
US5352832A (en) * | 1992-12-18 | 1994-10-04 | Schering Corporation | Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates |
EP0621033A1 (en) * | 1993-04-20 | 1994-10-26 | Nostras S.A. | Antibiotic composition containing oxytetracycline and glycofurol |
US5663361A (en) * | 1996-08-19 | 1997-09-02 | Schering Corporation | Process for preparing intermediates to florfenicol |
KR20040015624A (ko) * | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 플로르페니콜을 활성성분으로 함유하는 경구투여용약제학적 조성물 |
AR044437A1 (es) * | 2003-05-29 | 2005-09-14 | Schering Plough Ltd | Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino |
-
2005
- 2005-12-20 JP JP2007547484A patent/JP5017122B2/ja active Active
- 2005-12-20 MX MX2007007528A patent/MX2007007528A/es active IP Right Grant
- 2005-12-20 DE DE602005010479T patent/DE602005010479D1/de active Active
- 2005-12-20 BR BRPI0519157A patent/BRPI0519157B8/pt active IP Right Grant
- 2005-12-20 ES ES05825334T patent/ES2315942T3/es active Active
- 2005-12-20 PL PL05825334T patent/PL1830885T3/pl unknown
- 2005-12-20 EP EP05825334A patent/EP1830885B1/en active Active
- 2005-12-20 AT AT05825334T patent/ATE411046T1/de active
- 2005-12-20 SI SI200530518T patent/SI1830885T1/sl unknown
- 2005-12-20 WO PCT/EP2005/056950 patent/WO2006067138A2/en active Application Filing
- 2005-12-20 CA CA2591307A patent/CA2591307C/en active Active
- 2005-12-20 PT PT05825334T patent/PT1830885E/pt unknown
- 2005-12-20 DK DK05825334T patent/DK1830885T3/da active
- 2005-12-20 US US11/722,280 patent/US8680154B2/en active Active
- 2005-12-20 AU AU2005318187A patent/AU2005318187B2/en active Active
- 2005-12-21 AR ARP050105400A patent/AR052827A1/es not_active Application Discontinuation
-
2007
- 2007-06-06 NO NO20072880A patent/NO338532B1/no unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003097054A1 (en) * | 2002-05-20 | 2003-11-27 | Schering-Plough Ltd. | Compositions and method for treating infection in cattle and swine |
WO2004014340A1 (en) * | 2002-08-13 | 2004-02-19 | Dae Han New Pharm Co., Ltd. | Injectable composition comprising florfenicol as an active ingredient |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016515609A (ja) * | 2013-04-02 | 2016-05-30 | テミス メディケア リミティド | ジエチレングリコールモノエチルエーテル又は他のアルキル誘導体を含む医薬活性成分の組成物 |
Also Published As
Publication number | Publication date |
---|---|
BRPI0519157B8 (pt) | 2020-06-02 |
EP1830885B1 (en) | 2008-10-15 |
US20090275662A1 (en) | 2009-11-05 |
AR052827A1 (es) | 2007-04-04 |
DK1830885T3 (da) | 2009-01-05 |
AU2005318187B2 (en) | 2010-12-16 |
WO2006067138A2 (en) | 2006-06-29 |
EP1830885A2 (en) | 2007-09-12 |
JP5017122B2 (ja) | 2012-09-05 |
SI1830885T1 (sl) | 2009-02-28 |
US8680154B2 (en) | 2014-03-25 |
MX2007007528A (es) | 2007-10-08 |
BRPI0519157A2 (pt) | 2008-12-30 |
NO338532B1 (no) | 2016-08-29 |
PT1830885E (pt) | 2008-12-22 |
DE602005010479D1 (de) | 2008-11-27 |
ES2315942T3 (es) | 2009-04-01 |
ATE411046T1 (de) | 2008-10-15 |
CA2591307C (en) | 2012-12-04 |
AU2005318187A1 (en) | 2006-06-29 |
WO2006067138A3 (en) | 2006-09-21 |
PL1830885T3 (pl) | 2009-04-30 |
BRPI0519157B1 (pt) | 2020-05-19 |
CA2591307A1 (en) | 2006-06-29 |
NO20072880L (no) | 2007-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5017122B2 (ja) | 注射可能な獣医学組成物 | |
EP1505975B1 (en) | Compositions and method for treating infection in cattle and swine | |
EP0546018B1 (en) | Pharmaceutical composition of florfenicol | |
AU2004247053B2 (en) | Compositions for treating infection in cattle and swine | |
EP1713466B1 (en) | Antiparasitic composition containing an organic amine salt of closantel | |
TWI228048B (en) | New formulation | |
RU2397753C1 (ru) | Композиция для лечения бактериальных инфекций у животных | |
WO2013108180A1 (en) | Aqueous paracetamol composition for injection | |
NZ555774A (en) | Injectable veterinary composition comprising florfenicol, a pyrrolidone solvent and a cosolvent selected from diethyleneglycol monoethyl ether and / or tetrahydrofurfuryl alcohol polyethylene glycol ether | |
US20210106602A1 (en) | Injectable antibiotic formulations and use thereof | |
EP1875913A1 (en) | Compositions and method for treating infection in cattle and swine | |
AU2006233264A1 (en) | Compositions and method for treating infection in cattle and swine | |
JP2001524939A (ja) | ジヒドロポリプレノールの油組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081209 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111122 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120216 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120223 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120511 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120605 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120611 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150615 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5017122 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |